Biopharmaceutical Contract Manufacturing Market by Service (Manufacturing, Fill-Finish), Type (Drug Substance, Drug Product), Scale (Clinical), Source (Mammalian), Therapy Area (Oncology), Molecule Type (mAbs, ADC, CGT, Vaccines) - Global Forecast to 2030

The global biopharmaceutical contract manufacturing market is expected to reach USD 34.15 billion by 2030 from an estimated USD 22.40 billion in 2025, at a CAGR of 8.8% from 2025 to 2030. This growth in the biopharmaceutical contract manufacturing market is primarily driven by advancements in manufacturing technologies and a growing emphasis on personalized medicine. However, evolving regulations may pose challenges that could limit market expansion.

The monoclonal antibodies segment accounted for the largest share of the biopharmaceutical contract manufacturing market in 2024.

The biopharmaceutical contract manufacturing market is segmented by molecule type into monoclonal antibodies (mAbs), cell & gene therapy, antibody-drug conjugates, vaccines, therapeutic peptides & proteins, and other molecules. The mAbs segment leads the market due to the rising prevalence of chronic disorders like cancer and autoimmune diseases, driving the demand for targeted therapies. Monoclonal antibodies are preferred in clinical practice for their precision in targeting specific disease pathways. Government support for mAb research has encouraged biopharmaceutical firms to expand their pipelines, increasing the number of mAb candidates in clinical trials. Consequently, contract manufacturing organizations are experiencing a growing demand for their services to produce these advanced biologics efficiently and cost-effectively.

The mammalian expression systems segment dominated the market in 2024.

The mammalian expression systems segment dominates the global biopharmaceutical contract manufacturing market, primarily due to its critical role in creating complex biologics like monoclonal antibodies. This dominance stems from the ability of mammalian cell platforms to perform intricate post-translational modifications, enhancing treatment effectiveness. The rising demand for advanced biologics and increased investments in cell culture technologies have further solidified this segment. Contract manufacturing organizations are expanding their mammalian cell culture capabilities and adopting advanced technologies to improve yield and quality. As the pipeline for biologics grows, the mammalian expression systems segment is expected to continue driving growth and innovation in biopharmaceutical manufacturing.

Europe accounted for the second-largest share of the market from 2025 to 2030.

The biopharmaceutical contract manufacturing market in Europe is the second largest during the forecast period, driven by rising investments in biologics such as monoclonal antibodies and cell & gene therapies, along with expansions in biomanufacturing capacity. The region is a hub for innovation, focusing on advanced technologies that enhance quality and efficiency. For example, in March 2023, Lonza launched a cGMP manufacturing site for large-scale drug production, underscoring Europe’s commitment to meeting the global demand for complex biologics and attracting pharmaceutical and biotech firms seeking top-tier contract manufacturing services.

The primary interviews conducted for this report can be categorized as follows:

• By Respondent: Supply Side (70%) and Demand Side (30%)
• By Designation: Managers (45%), CXOs and Directors (30%), and Executives (25%)
• By Region: North America (40%), Europe (25%), the Asia Pacific (25%), Latin America (5%), and the Middle East & Africa (5%)

List of Key Companies Profiled in the Report:

Key players in the biopharmaceutical contract manufacturing market include Lonza (Switzerland), Thermo Fisher Scientific Inc. (US), WuXi Biologics (China), Catalent, Inc. (US), Samsung Biologics (South Korea), Boehringer Ingelheim International GmbH (Germany), FUJIFILM Holdings Corporation (Japan), AbbVie, Inc. (US), Eurofins Scientific (Luxembourg), GenScript Biotech Corporation (US), AGC Inc. (Japan), Merck KGaA (Germany), JSR Corporation (Japan), IDT Biologika (Germany), Ajinomoto Bio-Pharma (Japan), Agilent Technologies, Inc. (US), and Asahi Kasei Corporation (Japan).

Research Coverage:

This research report categorizes the biopharmaceutical contract manufacturing market by service (manufacturing, formulation & fill-finish, packaging & labeling, and other services), type (biologic drug substance manufacturing and biologic drug product manufacturing), scale of operation (clinical and commercial operations), source (mammalian and non-mammalian expression systems), therapeutic area (oncology, autoimmune diseases, metabolic diseases, cardiovascular diseases, neurology, infectious diseases, and other therapeutic areas), molecule type (monoclonal antibodies, antibody-drug conjugates, cell & gene therapy, vaccines, therapeutic peptides & proteins, and other molecules), and region (North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa).

The report provides a comprehensive analysis of the key factors affecting the growth of the biopharmaceutical contract manufacturing market, including drivers, restraints, challenges, and opportunities. It includes an in-depth examination of major industry players, offering insights into their business overviews, products, solutions, and key strategies, as well as their collaborations, partnerships, and agreements. Additionally, the report highlights recent developments related to new approvals and launches, mergers and acquisitions, and other significant activities in the biopharmaceutical contract manufacturing market.

Key Benefits of Buying the Report:

The report will assist both market leaders and new entrants by providing accurate revenue estimates for the overall biopharmaceutical contract manufacturing market and its subsegments. It will also help stakeholders better understand the competitive landscape, enabling them to better position their businesses and develop effective go-to-market strategies. Additionally, this report will offer insights into the market's dynamics, including key drivers, constraints, opportunities, and challenges.

The report provides insights on the following pointers:

• Analysis of key drivers (rising demand for outsourcing services, increasing demand for biologics & biosimilars, increased focus on personalized medicine, industrial collaborations for drug discovery and development/strategic partnerships and collaborations, and advancements in manufacturing technologies), restraints (challenges complying with regulatory reforms), opportunities (rising demand for cell & gene therapy, emerging countries market, and strong emphasis on drug development), and challenges (challenges to meet reformed regulations) influencing the growth of the market.
• Service Development/Innovation: Detailed insights on the upcoming technologies and research & development activities in the biopharmaceutical contract manufacturing market.
• Market Development: The report provides comprehensive information about profitable markets by analyzing them across various regions.
• Market Diversification: Exhaustive information about untapped geographies, recent developments, and investments in the biopharmaceutical contract manufacturing market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players. A detailed analysis of the key industry players has been done to provide insights into their key strategies, service launches/approvals, pipeline analysis, acquisitions, partnerships, agreements, collaborations, other recent developments, investment and funding activities, brand/product comparative analysis, and vendor valuation and financial metrics of the biopharmaceutical contract manufacturing market.

Tables List

Table 1 Biopharmaceutical Contract Manufacturing Market:

Inclusions & Exclusions

Table 2 Impact Analysis Of Supply-side And Demand-side Factors

Table 3 Biopharmaceutical Contract Manufacturing Market: Risk Analysis

Table 4 Biopharmaceutical Contract Manufacturing Market:

Impact Analysis Of Market Dynamics

Table 5 List Of Key Biosimilars Approved, 2023–2025

Table 6 List Of Expansions By Top Companies

Table 7 Biopharmaceutical Contract Manufacturing Market:

Role In Ecosystem

Table 8 Number Of Patents Filed In Biopharmaceutical Contract Manufacturing Market, 2014–2024

Table 9 Biopharmaceutical Contract Manufacturing Market:

Indicative List Of Patents, 2022

Table 10 North America: Regulatory Bodies, Government Agencies,

And Other Organizations

Table 11 Europe: Regulatory Bodies, Government Agencies,

And Other Organizations

Table 12 Asia Pacific: Regulatory Bodies, Government Agencies,

And Other Organizations

Table 13 Rest Of The World: Regulatory Bodies, Government Agencies, And Other Organizations

Table 14 Country-wise Regulatory Scenario For Contract Manufacturing

Table 15 Biopharmaceutical Contract Manufacturing Market: Detailed List Of Conferences & Events (2025–2026)

Table 16 Biopharmaceutical Contract Manufacturing Market: Porter’s Five Forces Analysis

Table 17 Influence Of Stakeholders On Buying Process Of Biopharmaceutical Contract Manufacturing Services (%)

Table 18 Key Buying Criteria For Biopharmaceutical Contract Manufacturing Services, By End User

Table 19 Us-adjusted Reciprocal Tariff Rates

Table 20 Biopharmaceutical Contract Manufacturing Market, By Service,

2023–2030 (Usd Million)

Table 21 Biopharmaceutical Contract Manufacturing Market For Manufacturing Services, By Region, 2023–2030 (Usd Million)

Table 22 North America: Biopharmaceutical Contract Manufacturing Market For Manufacturing Services, By Country, 2023–2030 (Usd Million)

Table 23 Europe: Biopharmaceutical Contract Manufacturing Market For Manufacturing Services, By Country, 2023–2030 (Usd Million)

Table 24 Asia Pacific: Biopharmaceutical Contract Manufacturing Market For Manufacturing Services, By Country, 2023–2030 (Usd Million)

Table 25 Latin America: Biopharmaceutical Contract Manufacturing Market For Manufacturing Services, By Country, 2023–2030 (Usd Million)

Table 26 Middle East: Biopharmaceutical Contract Manufacturing Market For Manufacturing Services, By Region, 2023–2030 (Usd Million)

Table 27 Biopharmaceutical Contract Manufacturing Market For Formulation & Fill-finish Services, By Region, 2023–2030 (Usd Million)

Table 28 North America: Biopharmaceutical Contract Manufacturing Market For Formulation & Fill-finish Services, By Country,

2023–2030 (Usd Million)

Table 29 Europe: Biopharmaceutical Contract Manufacturing Market For Formulation & Fill-finish Services, By Country, 2023–2030 (Usd Million)

Table 30 Asia Pacific: Biopharmaceutical Contract Manufacturing Market For Formulation & Fill-finish Services, By Country, 2023–2030 (Usd Million)

Table 31 Latin America: Biopharmaceutical Contract Manufacturing Market For Formulation & Fill-finish Services By Country, 2023–2030 (Usd Million)

Table 32 Middle East: Biopharmaceutical Contract Manufacturing Market For Formulation & Fill-finish Services, By Region, 2023–2030 (Usd Million)

Table 33 Biopharmaceutical Contract Manufacturing Market For Packaging & Labeling Services, By Region, 2023–2030 (Usd Million)

Table 34 North America: Biopharmaceutical Contract Manufacturing Market For Packaging & Labeling Services, By Country,

2023–2030 (Usd Million)

Table 35 Europe: Biopharmaceutical Contract Manufacturing Market For Packaging & Labeling Services, By Country, 2023–2030 (Usd Million)

Table 36 Asia Pacific: Biopharmaceutical Contract Manufacturing Market For Packaging & Labeling Services, By Country, 2023–2030 (Usd Million)

Table 37 Latin America: Biopharmaceutical Contract Manufacturing Market For Packaging & Labeling Services, By Country, 2023–2030 (Usd Million)

Table 38 Middle East: Biopharmaceutical Contract Manufacturing Market For Packaging & Labeling Services, By Region, 2023–2030 (Usd Million)

Table 39 Biopharmaceutical Contract Manufacturing Market For Other Services, By Region, 2023–2030 (Usd Million)

Table 40 North America: Biopharmaceutical Contract Manufacturing Market For Other Services, By Country, 2023–2030 (Usd Million)

Table 41 Europe: Biopharmaceutical Contract Manufacturing Market For Other Services, By Country, 2023–2030 (Usd Million)

Table 42 Asia Pacific: Biopharmaceutical Contract Manufacturing Market For Other Services, By Country, 2023–2030 (Usd Million)

Table 43 Latin America: Biopharmaceutical Contract Manufacturing Market For Other Services, By Country, 2023–2030 (Usd Million)

Table 44 Middle East: Biopharmaceutical Contract Manufacturing Market For Other Services, By Region, 2023–2030 (Usd Million)

Table 45 Biopharmaceutical Contract Manufacturing Market, By Type,

2023–2030 (Usd Million)

Table 46 Biologic Drug Substance Manufacturing Market, By Region,

2023–2030 (Usd Million)

Table 47 North America: Biologic Drug Substance Manufacturing Market,

By Country, 2023–2030 (Usd Million)

Table 48 Europe: Biologic Drug Substance Manufacturing Market,

By Country, 2023–2030 (Usd Million)

Table 49 Asia Pacific: Biologic Drug Substance Manufacturing Market,

By Country, 2023–2030 (Usd Million)

Table 50 Latin America: Biologic Drug Substance Manufacturing Market,

By Country, 2023–2030 (Usd Million)

Table 51 Middle East: Biologic Drug Substance Manufacturing Market,

By Region, 2023–2030 (Usd Million)

Table 52 Biologic Drug Product Manufacturing Market, By Region,

2023–2030 (Usd Million)

Table 53 North America: Biologic Drug Product Manufacturing Market,

By Country, 2023–2030 (Usd Million)

Table 54 Europe: Biologic Drug Product Manufacturing Market, By Country, 2023–2030 (Usd Million)

Table 55 Asia Pacific: Biologic Drug Product Manufacturing Market,

By Country, 2023–2030 (Usd Million)

Table 56 Latin America: Biologic Drug Product Manufacturing Market,

By Country, 2023–2030 (Usd Million)

Table 57 Middle East: Biologic Drug Product Manufacturing Market,

By Region, 2023–2030 (Usd Million)

Table 58 Biopharmaceutical Contract Manufacturing Market,

By Scale Of Operation, 2023–2030 (Usd Million)

Table 59 Biopharmaceutical Contract Manufacturing Market For Commercial Operations, By Region, 2023–2030 (Usd Million)

Table 60 North America: Biopharmaceutical Contract Manufacturing Market For Commercial Operations, By Country, 2023–2030 (Usd Million)

Table 61 Europe: Biopharmaceutical Contract Manufacturing Market For Commercial Operations, By Country, 2023–2030 (Usd Million)

Table 62 Asia Pacific: Biopharmaceutical Contract Manufacturing Market For Commercial Operations, By Country, 2023–2030 (Usd Million)

Table 63 Latin America: Biopharmaceutical Contract Manufacturing Market For Commercial Operations, By Country, 2023–2030 (Usd Million)

Table 64 Middle East: Biopharmaceutical Contract Manufacturing Market For Commercial Operations, By Region, 2023–2030 (Usd Million)

Table 65 Biopharmaceutical Contract Manufacturing Market For Clinical Operations, By Region, 2023–2030 (Usd Million)

Table 66 North America: Biopharmaceutical Contract Manufacturing Market For Clinical Operations, By Country, 2023–2030 (Usd Million)

Table 67 Europe: Biopharmaceutical Contract Manufacturing Market For Clinical Operations, By Country, 2023–2030 (Usd Million)

Table 68 Asia Pacific: Biopharmaceutical Contract Manufacturing Market For Clinical Operations, By Country, 2023–2030 (Usd Million)

Table 69 Latin America: Biopharmaceutical Contract Manufacturing Market For Clinical Operations, By Country, 2023–2030 (Usd Million)

Table 70 Middle East: Biopharmaceutical Contract Manufacturing Market For Clinical Operations, By Region, 2023–2030 (Usd Million)

Table 71 Biopharmaceutical Contract Manufacturing Market,

By Source, 2023–2030 (Usd Million)

Table 72 Types Of Mammalian Expression Systems

Table 73 Biopharmaceutical Contract Manufacturing Market For Mammalian Expression Systems, By Region, 2023–2030 (Usd Million)

Table 74 North America: Biopharmaceutical Contract Manufacturing Market For Mammalian Expression Systems, By Country,

2023–2030 (Usd Million)

Table 75 Europe: Biopharmaceutical Contract Manufacturing Market For Mammalian Expression Systems, By Country, 2023–2030 (Usd Million)

Table 76 Asia Pacific: Biopharmaceutical Contract Manufacturing Market For Mammalian Expression Systems, By Country, 2023–2030 (Usd Million)

Table 77 Latin America: Biopharmaceutical Contract Manufacturing Market For Mammalian Expression Systems, By Country, 2023–2030 (Usd Million)

Table 78 Middle East: Biopharmaceutical Contract Manufacturing Market For Mammalian Expression Systems, By Region, 2023–2030 (Usd Million)

Table 79 Types Of Microbial Expression Systems And Their Applications

Table 80 Biopharmaceutical Contract Manufacturing Market For Non-mammalian Expression Systems, By Region, 2023–2030 (Usd Million)

Table 81 North America: Biopharmaceutical Contract Manufacturing Market For Non-mammalian Expression Systems, By Country,

2023–2030 (Usd Million)

Table 82 Europe: Biopharmaceutical Contract Manufacturing Market For Non-mammalian Expression Systems, By Country, 2023–2030 (Usd Million)

Table 83 Asia Pacific: Biopharmaceutical Contract Manufacturing Market For Non-mammalian Expression Systems, By Country,

2023–2030 (Usd Million)

Table 84 Latin America: Biopharmaceutical Contract Manufacturing Market For Non-mammalian Expression Systems, By Country,

2023–2030 (Usd Million)

Table 85 Middle East: Biopharmaceutical Contract Manufacturing Market For Non-mammalian Expression Systems, By Region,

2023–2030 (Usd Million)

Table 86 Biopharmaceutical Contract Manufacturing Market, By Molecule Type, 2023–2030 (Usd Million)

Table 87 Biopharmaceutical Contract Manufacturing Market For Monoclonal Antibodies, By Region, 2023–2030 (Usd Million)

Table 88 North America: Biopharmaceutical Contract Manufacturing Market For Monoclonal Antibodies, By Country, 2023–2030 (Usd Million)

Table 89 Europe: Biopharmaceutical Contract Manufacturing Market For Monoclonal Antibodies, By Country, 2023–2030 (Usd Million)

Table 90 Asia Pacific: Biopharmaceutical Contract Manufacturing Market For Monoclonal Antibodies, By Country, 2023–2030 (Usd Million)

Table 91 Latin America: Biopharmaceutical Contract Manufacturing Market For Monoclonal Antibodies, By Country, 2023–2030 (Usd Million)

Table 92 Middle East: Biopharmaceutical Contract Manufacturing Market For Monoclonal Antibodies, By Region, 2023–2030 (Usd Million)

Table 93 Fda-approved Car T-cell Therapies

Table 94 Biopharmaceutical Contract Manufacturing Market For Cell & Gene Therapy, By Region, 2023–2030 (Usd Million)

Table 95 North America: Biopharmaceutical Contract Manufacturing Market For Cell & Gene Therapy, By Country, 2023–2030 (Usd Million)

Table 96 Europe: Biopharmaceutical Contract Manufacturing Market For Cell & Gene Therapy, By Country, 2023–2030 (Usd Million)

Table 97 Asia Pacific: Biopharmaceutical Contract Manufacturing Market For Cell & Gene Therapy, By Country, 2023–2030 (Usd Million)

Table 98 Latin America: Biopharmaceutical Contract Manufacturing Market For Cell & Gene Therapy, By Country, 2023–2030 (Usd Million)

Table 99 Middle East: Biopharmaceutical Contract Manufacturing Market For Cell & Gene Therapy, By Region, 2023–2030 (Usd Million)

Table 100 Biopharmaceutical Contract Manufacturing Market For Antibody-drug Conjugates, By Region, 2023–2030 (Usd Million)

Table 101 North America: Biopharmaceutical Contract Manufacturing Market For Antibody-drug Conjugates, By Country, 2023–2030 (Usd Million)

Table 102 Europe: Biopharmaceutical Contract Manufacturing Market For Antibody-drug Conjugates, By Country, 2023–2030 (Usd Million)

Table 103 Asia Pacific: Biopharmaceutical Contract Manufacturing Market For Antibody-drug Conjugates, By Country, 2023–2030 (Usd Million)

Table 104 Latin America: Biopharmaceutical Contract Manufacturing Market For Antibody-drug Conjugates, By Country, 2023–2030 (Usd Million)

Table 105 Middle East: Biopharmaceutical Contract Manufacturing Market For Antibody-drug Conjugates, By Region, 2023–2030 (Usd Million)

Table 106 Nih Funding For Vaccine Research, 2018–2024 (Usd Million)

Table 107 Biopharmaceutical Contract Manufacturing Market For Vaccines,

By Region, 2023–2030 (Usd Million)

Table 108 North America: Biopharmaceutical Contract Manufacturing Market For Vaccines, By Country, 2023–2030 (Usd Million)

Table 109 Europe: Biopharmaceutical Contract Manufacturing Market For Vaccines, By Country, 2023–2030 (Usd Million)

Table 110 Asia Pacific: Biopharmaceutical Contract Manufacturing Market

For Vaccines, By Country, 2023–2030 (Usd Million)

Table 111 Latin America: Biopharmaceutical Contract Manufacturing Market

For Vaccines, By Country, 2023–2030 (Usd Million)

Table 112 Middle East: Biopharmaceutical Contract Manufacturing Market

For Vaccines, By Region, 2023–2030 (Usd Million)

Table 113 Examples Of Peptide Therapeutics

Table 114 Commercialized Recombinant Proteins Used In Medicine

Table 115 Biopharmaceutical Contract Manufacturing Market For Therapeutic Peptides & Proteins, By Region, 2023–2030 (Usd Million)

Table 116 North America: Biopharmaceutical Contract Manufacturing Market For Therapeutic Peptides & Proteins, By Country,

2023–2030 (Usd Million)

Table 117 Europe: Biopharmaceutical Contract Manufacturing Market For Therapeutic Peptides & Proteins, By Country, 2023–2030 (Usd Million)

Table 118 Asia Pacific: Biopharmaceutical Contract Manufacturing Market For Therapeutic Peptides & Proteins, By Country, 2023–2030 (Usd Million)

Table 119 Latin America: Biopharmaceutical Contract Manufacturing Market For Therapeutic Peptides & Proteins, By Country, 2023–2030 (Usd Million)

Table 120 Middle East: Biopharmaceutical Contract Manufacturing Market For Therapeutic Peptides & Proteins, By Region, 2023–2030 (Usd Million)

Table 121 Biopharmaceutical Contract Manufacturing Market For Other Molecules, By Region, 2023–2030 (Usd Million)

Table 122 North America: Biopharmaceutical Contract Manufacturing Market For Other Molecules, By Country, 2023–2030 (Usd Million)

Table 123 Europe: Biopharmaceutical Contract Manufacturing Market

For Other Molecules, By Country, 2023–2030 (Usd Million)

Table 124 Asia Pacific: Biopharmaceutical Contract Manufacturing Market

For Other Molecules, By Country, 2023–2030 (Usd Million)

Table 125 Latin America: Biopharmaceutical Contract Manufacturing Market

For Other Molecules, By Country, 2023–2030 (Usd Million)

Table 126 Middle East: Biopharmaceutical Contract Manufacturing Market

For Other Molecules, By Region, 2023–2030 (Usd Million)

Table 127 Biopharmaceutical Contract Manufacturing Market, By Therapeutic Area, 2023–2030 (Usd Million)

Table 128 Biopharmaceutical Contract Manufacturing Market For Oncology,

By Region, 2023–2030 (Usd Million)

Table 129 North America: Biopharmaceutical Contract Manufacturing Market For Oncology, By Country, 2023–2030 (Usd Million)

Table 130 Europe: Biopharmaceutical Contract Manufacturing Market

For Oncology, By Country, 2023–2030 (Usd Million)

Table 131 Asia Pacific: Biopharmaceutical Contract Manufacturing Market

For Oncology, By Country, 2023–2030 (Usd Million)

Table 132 Latin America: Biopharmaceutical Contract Manufacturing Market

For Oncology, By Country, 2023–2030 (Usd Million)

Table 133 Middle East: Biopharmaceutical Contract Manufacturing Market

For Oncology, By Region, 2023–2030 (Usd Million)

Table 134 Biopharmaceutical Contract Manufacturing Market For Autoimmune Diseases, By Region, 2023–2030 (Usd Million)

Table 135 North America: Biopharmaceutical Contract Manufacturing Market For Autoimmune Diseases, By Country, 2023–2030 (Usd Million)

Table 136 Europe: Biopharmaceutical Contract Manufacturing Market

For Autoimmune Diseases, By Country, 2023–2030 (Usd Million)

Table 137 Asia Pacific: Biopharmaceutical Contract Manufacturing Market

For Autoimmune Diseases, By Country, 2023–2030 (Usd Million)

Table 138 Latin America: Biopharmaceutical Contract Manufacturing Market

For Autoimmune Diseases, By Country, 2023–2030 (Usd Million)

Table 139 Middle East: Biopharmaceutical Contract Manufacturing Market For Autoimmune Diseases, By Region, 2023–2030 (Usd Million)

Table 140 Biopharmaceutical Contract Manufacturing Market For Cardiovascular Diseases, By Region, 2023–2030 (Usd Million)

Table 141 North America: Biopharmaceutical Contract Manufacturing Market For Cardiovascular Diseases, By Country, 2023–2030 (Usd Million)

Table 142 Europe: Biopharmaceutical Contract Manufacturing Market For Cardiovascular Diseases, By Country, 2023–2030 (Usd Million)

Table 143 Asia Pacific: Biopharmaceutical Contract Manufacturing Market

For Cardiovascular Diseases, By Country, 2023–2030 (Usd Million)

Table 144 Latin America: Biopharmaceutical Contract Manufacturing Market

For Cardiovascular Diseases, By Country, 2023–2030 (Usd Million)

Table 145 Middle East: Biopharmaceutical Contract Manufacturing Market

For Cardiovascular Diseases, By Region, 2023–2030 (Usd Million)

Table 146 Biopharmaceutical Contract Manufacturing Market For Metabolic Diseases, By Region, 2023–2030 (Usd Million)

Table 147 North America: Biopharmaceutical Contract Manufacturing Market For Metabolic Diseases, By Country, 2023–2030 (Usd Million)

Table 148 Europe: Biopharmaceutical Contract Manufacturing Market

For Metabolic Diseases, By Country, 2023–2030 (Usd Million)

Table 149 Asia Pacific: Biopharmaceutical Contract Manufacturing Market

For Metabolic Diseases, By Country, 2023–2030 (Usd Million)

Table 150 Latin America: Biopharmaceutical Contract Manufacturing Market

For Metabolic Diseases, By Country, 2023–2030 (Usd Million)

Table 151 Middle East: Biopharmaceutical Contract Manufacturing Market For Metabolic Diseases, By Region, 2023–2030 (Usd Million)

Table 152 Biopharmaceutical Contract Manufacturing Market For Infectious Diseases, By Region, 2023–2030 (Usd Million)

Table 153 North America: Biopharmaceutical Contract Manufacturing Market For Infectious Diseases, By Country, 2023–2030 (Usd Million)

Table 154 Europe: Biopharmaceutical Contract Manufacturing Market For Infectious Diseases, By Country, 2023–2030 (Usd Million)

Table 155 Asia Pacific: Biopharmaceutical Contract Manufacturing Market

For Infectious Diseases, By Country, 2023–2030 (Usd Million)

Table 156 Latin America: Biopharmaceutical Contract Manufacturing Market

For Infectious Diseases, By Country, 2023–2030 (Usd Million)

Table 157 Middle East: Biopharmaceutical Contract Manufacturing Market For Infectious Diseases, By Region, 2023–2030 (Usd Million)

Table 158 Biopharmaceutical Contract Manufacturing Market For Neurology,

By Region, 2023–2030 (Usd Million)

Table 159 North America: Biopharmaceutical Contract Manufacturing Market For Neurology, By Country, 2023–2030 (Usd Million)

Table 160 Europe: Biopharmaceutical Contract Manufacturing Market

For Neurology, By Country, 2023–2030 (Usd Million)

Table 161 Asia Pacific: Biopharmaceutical Contract Manufacturing Market

For Neurology, By Country, 2023–2030 (Usd Million)

Table 162 Latin America: Biopharmaceutical Contract Manufacturing Market

For Neurology, By Country, 2023–2030 (Usd Million)

Table 163 Middle East: Biopharmaceutical Contract Manufacturing Market

For Neurology, By Region 2023–2030 (Usd Million)

Table 164 Biopharmaceutical Contract Manufacturing Market For Other Therapeutic Areas, By Region, 2023–2030 (Usd Million)

Table 165 North America: Biopharmaceutical Contract Manufacturing Market For Other Therapeutic Areas, By Country, 2023–2030 (Usd Million)

Table 166 Europe: Biopharmaceutical Contract Manufacturing Market

For Other Therapeutic Areas, By Country, 2023–2030 (Usd Million)

Table 167 Asia Pacific: Biopharmaceutical Contract Manufacturing Market

For Other Therapeutic Areas, By Country, 2023–2030 (Usd Million)

Table 168 Latin America: Biopharmaceutical Contract Manufacturing Market

For Other Therapeutic Areas, By Country, 2023–2030 (Usd Million)

Table 169 Middle East: Biopharmaceutical Contract Manufacturing Market

For Other Therapeutic Areas, By Region, 2023–2030 (Usd Million)

Table 170 Biopharmaceutical Contract Manufacturing Market, By Region,

2023–2030 (Usd Million)

Table 171 North America: Key Macroindicators

Table 172 North America: Biopharmaceutical Contract Manufacturing Market,

By Country, 2023–2030 (Usd Million)

Table 173 North America: Biopharmaceutical Contract Manufacturing Market,

By Service, 2023–2030 (Usd Million)

Table 174 North America: Biopharmaceutical Contract Manufacturing Market,

By Type, 2023–2030 (Usd Million)

Table 175 North America: Biopharmaceutical Contract Manufacturing Market,

By Scale Of Operation, 2023–2030 (Usd Million)

Table 176 North America: Biopharmaceutical Contract Manufacturing Market,

By Source, 2023–2030 (Usd Million)

Table 177 North America: Biopharmaceutical Contract Manufacturing Market,

By Molecule Type, 2023–2030 (Usd Million)

Table 178 North America: Biopharmaceutical Contract Manufacturing Market,

By Therapeutic Area, 2023–2030 (Usd Million)

Table 179 Us: Biopharmaceutical Contract Manufacturing Market, By Service, 2023–2030 (Usd Million)

Table 180 Us: Biopharmaceutical Contract Manufacturing Market, By Type,

2023–2030 (Usd Million)

Table 181 Us: Biopharmaceutical Contract Manufacturing Market,

By Scale Of Operation, 2023–2030 (Usd Million)

Table 182 Us: Biopharmaceutical Contract Manufacturing Market,

By Source, 2023–2030 (Usd Million)

Table 183 Us: Biopharmaceutical Contract Manufacturing Market,

By Molecule Type, 2023–2030 (Usd Million)

Table 184 Us: Biopharmaceutical Contract Manufacturing Market,

By Therapeutic Area, 2023–2030 (Usd Million)

Table 185 Canada: Biopharmaceutical Contract Manufacturing Market,

By Service, 2023–2030 (Usd Million)

Table 186 Canada: Biopharmaceutical Contract Manufacturing Market,

By Type, 2023–2030 (Usd Million)

Table 187 Canada: Biopharmaceutical Contract Manufacturing Market,

By Scale Of Operation, 2023–2030 (Usd Million)

Table 188 Canada: Biopharmaceutical Contract Manufacturing Market,

By Source, 2023–2030 (Usd Million)

Table 189 Canada: Biopharmaceutical Contract Manufacturing Market,

By Molecule Type, 2023–2030 (Usd Million)

Table 190 Canada: Biopharmaceutical Contract Manufacturing Market,

By Therapeutic Area, 2023–2030 (Usd Million)

Table 191 Europe: Key Macroindicators

Table 192 Europe: Biopharmaceutical Contract Manufacturing Market,

By Country, 2023–2030 (Usd Million)

Table 193 Europe: Biopharmaceutical Contract Manufacturing Market,

By Service, 2023–2030 (Usd Million)

Table 194 Europe: Biopharmaceutical Contract Manufacturing Market,

By Type, 2023–2030 (Usd Million)

Table 195 Europe: Biopharmaceutical Contract Manufacturing Market,

By Scale Of Operation, 2023–2030 (Usd Million)

Table 196 Europe: Biopharmaceutical Contract Manufacturing Market,

By Source, 2023–2030 (Usd Million)

Table 197 Europe: Biopharmaceutical Contract Manufacturing Market,

By Molecule Type, 2023–2030 (Usd Million)

Table 198 Europe: Biopharmaceutical Contract Manufacturing Market,

By Therapeutic Area, 2023–2030 (Usd Million)

Table 199 Germany: Biopharmaceutical Contract Manufacturing Market,

By Service, 2023–2030 (Usd Million)

Table 200 Germany: Biopharmaceutical Contract Manufacturing Market,

By Type, 2023–2030 (Usd Million)

Table 201 Germany: Biopharmaceutical Contract Manufacturing Market,

By Scale Of Operation, 2023–2030 (Usd Million)

Table 202 Germany: Biopharmaceutical Contract Manufacturing Market,

By Source, 2023–2030 (Usd Million)

Table 203 Germany: Biopharmaceutical Contract Manufacturing Market,

By Molecule Type, 2023–2030 (Usd Million)

Table 204 Germany: Biopharmaceutical Contract Manufacturing Market,

By Therapeutic Area, 2023–2030 (Usd Million)

Table 205 Uk: Biopharmaceutical Contract Manufacturing Market, By Service, 2023–2030 (Usd Million)

Table 206 Uk: Biopharmaceutical Contract Manufacturing Market, By Type,

2023–2030 (Usd Million)

Table 207 Uk: Biopharmaceutical Contract Manufacturing Market,

By Scale Of Operation, 2023–2030 (Usd Million)

Table 208 Uk: Biopharmaceutical Contract Manufacturing Market,

By Source, 2023–2030 (Usd Million)

Table 209 Uk: Biopharmaceutical Contract Manufacturing Market,

By Molecule Type, 2023–2030 (Usd Million)

Table 210 Uk: Biopharmaceutical Contract Manufacturing Market,

By Therapeutic Area, 2023–2030 (Usd Million)

Table 211 France: Biopharmaceutical Contract Manufacturing Market,

By Service, 2023–2030 (Usd Million)

Table 212 France: Biopharmaceutical Contract Manufacturing Market,

By Type, 2023–2030 (Usd Million)

Table 213 France: Biopharmaceutical Contract Manufacturing Market,

By Scale Of Operation, 2023–2030 (Usd Million)

Table 214 France: Biopharmaceutical Contract Manufacturing Market,

By Source, 2023–2030 (Usd Million)

Table 215 France: Biopharmaceutical Contract Manufacturing Market,

By Molecule Type, 2023–2030 (Usd Million)

Table 216 France: Biopharmaceutical Contract Manufacturing Market,

By Therapeutic Area, 2023–2030 (Usd Million)

Table 217 Italy: Biopharmaceutical Contract Manufacturing Market,

By Service, 2023–2030 (Usd Million)

Table 218 Italy: Biopharmaceutical Contract Manufacturing Market,

By Type, 2023–2030 (Usd Million)

Table 219 Italy: Biopharmaceutical Contract Manufacturing Market,

By Scale Of Operation, 2023–2030 (Usd Million)

Table 220 Italy: Biopharmaceutical Contract Manufacturing Market,

By Source, 2023–2030 (Usd Million)

Table 221 Italy: Biopharmaceutical Contract Manufacturing Market,

By Molecule Type, 2023–2030 (Usd Million)

Table 222 Italy: Biopharmaceutical Contract Manufacturing Market,

By Therapeutic Area, 2023–2030 (Usd Million)

Table 223 Spain: Biopharmaceutical Contract Manufacturing Market,

By Service, 2023–2030 (Usd Million)

Table 224 Spain: Biopharmaceutical Contract Manufacturing Market,

By Type, 2023–2030 (Usd Million)

Table 225 Spain: Biopharmaceutical Contract Manufacturing Market,

By Scale Of Operation, 2023–2030 (Usd Million)

Table 226 Spain: Biopharmaceutical Contract Manufacturing Market,

By Source, 2023–2030 (Usd Million)

Table 227 Spain: Biopharmaceutical Contract Manufacturing Market,

By Molecule Type, 2023–2030 (Usd Million)

Table 228 Spain: Biopharmaceutical Contract Manufacturing Market,

By Therapeutic Area, 2023–2030 (Usd Million)

Table 229 Switzerland: Biopharmaceutical Contract Manufacturing Market,

By Service, 2023–2030 (Usd Million)

Table 230 Switzerland: Biopharmaceutical Contract Manufacturing Market,

By Type, 2023–2030 (Usd Million)

Table 231 Switzerland: Biopharmaceutical Contract Manufacturing Market,

By Scale Of Operation, 2023–2030 (Usd Million)

Table 232 Switzerland: Biopharmaceutical Contract Manufacturing Market,

By Source, 2023–2030 (Usd Million)

Table 233 Switzerland: Biopharmaceutical Contract Manufacturing Market,

By Molecule Type, 2023–2030 (Usd Million)

Table 234 Switzerland: Biopharmaceutical Contract Manufacturing Market,

By Therapeutic Area, 2023–2030 (Usd Million)

Table 235 Ireland: Biopharmaceutical Contract Manufacturing Market,

By Service, 2023–2030 (Usd Million)

Table 236 Ireland: Biopharmaceutical Contract Manufacturing Market,

By Type, 2023–2030 (Usd Million)

Table 237 Ireland: Biopharmaceutical Contract Manufacturing Market,

By Scale Of Operation, 2023–2030 (Usd Million)

Table 238 Ireland: Biopharmaceutical Contract Manufacturing Market,

By Source, 2023–2030 (Usd Million)

Table 239 Ireland: Biopharmaceutical Contract Manufacturing Market,

By Molecule Type, 2023–2030 (Usd Million)

Table 240 Ireland: Biopharmaceutical Contract Manufacturing Market,

By Therapeutic Area, 2023–2030 (Usd Million)

Table 241 Rest Of Europe: Biopharmaceutical Contract Manufacturing Market, By Service, 2023–2030 (Usd Million)

Table 242 Rest Of Europe: Biopharmaceutical Contract Manufacturing Market, By Type, 2023–2030 (Usd Million)

Table 243 Rest Of Europe: Biopharmaceutical Contract Manufacturing Market, By Scale Of Operation, 2023–2030 (Usd Million)

Table 244 Rest Of Europe: Biopharmaceutical Contract Manufacturing Market, By Source, 2023–2030 (Usd Million)

Table 245 Rest Of Europe: Biopharmaceutical Contract Manufacturing Market, By Molecule Type, 2023–2030 (Usd Million)

Table 246 Rest Of Europe: Biopharmaceutical Contract Manufacturing Market, By Therapeutic Area, 2023–2030 (Usd Million)

Table 247 Asia Pacific: Key Macroindicators

Table 248 Asia Pacific: Biopharmaceutical Contract Manufacturing Market,

By Country, 2023–2030 (Usd Million)

Table 249 Asia Pacific: Biopharmaceutical Contract Manufacturing Market,

By Service, 2023–2030 (Usd Million)

Table 250 Asia Pacific: Biopharmaceutical Contract Manufacturing Market,

By Type, 2023–2030 (Usd Million)

Table 251 Asia Pacific: Biopharmaceutical Contract Manufacturing Market,

By Scale Of Operation, 2023–2030 (Usd Million)

Table 252 Asia Pacific: Biopharmaceutical Contract Manufacturing Market,

By Source, 2023–2030 (Usd Million)

Table 253 Asia Pacific: Biopharmaceutical Contract Manufacturing Market,

By Molecule Type, 2023–2030 (Usd Million)

Table 254 Asia Pacific: Biopharmaceutical Contract Manufacturing Market,

By Therapeutic Area, 2023–2030 (Usd Million)

Table 255 China: Biopharmaceutical Contract Manufacturing Market, By Service, 2023–2030 (Usd Million)

Table 256 China: Biopharmaceutical Contract Manufacturing Market, By Type, 2023–2030 (Usd Million)

Table 257 China: Biopharmaceutical Contract Manufacturing Market, By Scale Of Operation, 2023–2030 (Usd Million)

Table 258 China: Biopharmaceutical Contract Manufacturing Market, By Source, 2023–2030 (Usd Million)

Table 259 China: Biopharmaceutical Contract M anufacturing Market,

By Molecule Type, 2023–2030 (Usd Million)

Table 260 China: Biopharmaceutical Contract Manufacturing Market,

By Therapeutic Area, 2023–2030 (Usd Million)

Table 261 Japan: Biopharmaceutical Contract Manufacturing Market, By Service, 2023–2030 (Usd Million)

Table 262 Japan: Biopharmaceutical Contract Manufacturing Market,

By Type, 2023–2030 (Usd Million)

Table 263 Japan: Biopharmaceutical Contract Manufacturing Market,

By Scale Of Operation, 2023–2030 (Usd Million)

Table 264 Japan: Biopharmaceutical Contract Manufacturing Market,

By Source, 2023–2030 (Usd Million)

Table 265 Japan: Biopharmaceutical Contract Manufacturing Market,

By Molecule Type, 2023–2030 (Usd Million)

Table 266 Japan: Biopharmaceutical Contract Manufacturing Market,

By Therapeutic Area, 2023–2030 (Usd Million)

Table 267 India: Biopharmaceutical Contract Manufacturing Market,

By Service, 2023–2030 (Usd Million)

Table 268 India: Biopharmaceutical Contract Manufacturing Market,

By Type, 2023–2030 (Usd Million)

Table 269 India: Biopharmaceutical Contract Manufacturing Market,

By Scale Of Operation, 2023–2030 (Usd Million)

Table 270 India: Biopharmaceutical Contract Manufacturing Market,

By Source, 2023–2030 (Usd Million)

Table 271 India: Biopharmaceutical Contract Manufacturing Market,

By Molecule Type, 2023–2030 (Usd Million)

Table 272 India: Biopharmaceutical Contract Manufacturing Market, By Therapeutic Area, 2023–2030 (Usd Million)

Table 273 South Korea: Biopharmaceutical Contract Manufacturing Market,

By Service, 2023–2030 (Usd Million)

Table 274 South Korea: Biopharmaceutical Contract Manufacturing Market,

By Type, 2023–2030 (Usd Million)

Table 275 South Korea: Biopharmaceutical Contract Manufacturing Market,

By Scale Of Operation, 2023–2030 (Usd Million)

Table 276 South Korea: Biopharmaceutical Contract Manufacturing Market,

By Source, 2023–2030 (Usd Million)

Table 277 South Korea: Biopharmaceutical Contract Manufacturing Market,

By Molecule Type, 2023–2030 (Usd Million)

Table 278 South Korea: Biopharmaceutical Contract Manufacturing Market,

By Therapeutic Area, 2023–2030 (Usd Million)

Table 279 Rest Of Asia Pacific: Biopharmaceutical Contract Manufacturing Market, By Service, 2023–2030 (Usd Million)

Table 280 Rest Of Asia Pacific: Biopharmaceutical Contract Manufacturing Market, By Type, 2023–2030 (Usd Million)

Table 281 Rest Of Asia Pacific: Biopharmaceutical Contract Manufacturing Market, By Scale Of Operation, 2023–2030 (Usd Million)

Table 282 Rest Of Asia Pacific: Biopharmaceutical Contract Manufacturing Market, By Source, 2023–2030 (Usd Million)

Table 283 Rest Of Asia Pacific: Biopharmaceutical Contract Manufacturing Market, By Molecule Type, 2023–2030 (Usd Million)

Table 284 Rest Of Asia Pacific: Biopharmaceutical Contract Manufacturing Market, By Therapeutic Area, 2023–2030 (Usd Million)

Table 285 Latin America: Key Macroindicators

Table 286 Latin America: Biopharmaceutical Contract Manufacturing Market,

By Country, 2023–2030 (Usd Million)

Table 287 Latin America: Biopharmaceutical Contract Manufacturing Market,

By Service, 2023–2030 (Usd Million)

Table 288 Latin America: Biopharmaceutical Contract Manufacturing Market,

By Type, 2023–2030 (Usd Million)

Table 289 Latin America: Biopharmaceutical Contract Manufacturing Market,

By Scale Of Operation, 2023–2030 (Usd Million)

Table 290 Latin America: Biopharmaceutical Contract Manufacturing Market,

By Source, 2023–2030 (Usd Million)

Table 291 Latin America: Biopharmaceutical Contract Manufacturing Market,

By Molecule Type, 2023–2030 (Usd Million)

Table 292 Latin America: Biopharmaceutical Contract Manufacturing Market,

By Therapeutic Area, 2023–2030 (Usd Million)

Table 293 Brazil: Biopharmaceutical Contract Manufacturing Market, By Service, 2023–2030 (Usd Million)

Table 294 Brazil: Biopharmaceutical Contract Manufacturing Market, By Type, 2023–2030 (Usd Million)

Table 295 Brazil: Biopharmaceutical Contract Manufacturing Market, By Scale Of Operation, 2023–2030 (Usd Million)

Table 296 Brazil: Biopharmaceutical Contract Manufacturing Market, By Source, 2023–2030 (Usd Million)

Table 297 Brazil: Biopharmaceutical Contract Manufacturing Market,

By Molecule Type, 2023–2030 (Usd Million)

Table 298 Brazil: Biopharmaceutical Contract Manufacturing Market,

By Therapeutic Area, 2023–2030 (Usd Million)

Table 299 Mexico: Biopharmaceutical Contract Manufacturing Market,

By Service, 2023–2030 (Usd Million)

Table 300 Mexico: Biopharmaceutical Contract Manufacturing Market,

By Type, 2023–2030 (Usd Million)

Table 301 Mexico: Biopharmaceutical Contract Manufacturing Market,

By Scale Of Operation, 2023–2030 (Usd Million)

Table 302 Mexico: Biopharmaceutical Contract Manufacturing Market,

By Source, 2023–2030 (Usd Million)

Table 303 Mexico: Biopharmaceutical Contract Manufacturing Market,

By Molecule Type, 2023–2030 (Usd Million)

Table 304 Mexico: Biopharmaceutical Contract Manufacturing Market,

By Therapeutic Area, 2023–2030 (Usd Million)

Table 305 Rest Of Latin America: Biopharmaceutical Contract Manufacturing Market, By Service, 2023–2030 (Usd Million)

Table 306 Rest Of Latin America: Biopharmaceutical Contract Manufacturing Market, By Type, 2023–2030 (Usd Million)

Table 307 Rest Of Latin America: Biopharmaceutical Contract Manufacturing Market, By Scale Of Operation, 2023–2030 (Usd Million)

Table 308 Rest Of Latin America: Biopharmaceutical Contract Manufacturing Market, By Source, 2023–2030 (Usd Million)

Table 309 Rest Of Latin America: Biopharmaceutical Contract Manufacturing Market, By Molecule Type, 2023–2030 (Usd Million)

Table 310 Rest Of Latin America: Biopharmaceutical Contract Manufacturing Market, By Therapeutic Area, 2023–2030 (Usd Million)

Table 311 Middle East: Key Macroindicators

Table 312 Middle East: Biopharmaceutical Contract Manufacturing Market,

By Region, 2023–2030 (Usd Million)

Table 313 Middle East: Biopharmaceutical Contract Manufacturing Market,

By Service, 2023–2030 (Usd Million)

Table 314 Middle East: Biopharmaceutical Contract Manufacturing Market,

By Type, 2023–2030 (Usd Million)

Table 315 Middle East: Biopharmaceutical Contract Manufacturing Market,

By Scale Of Operation, 2023–2030 (Usd Million)

Table 316 Middle East: Biopharmaceutical Contract Manufacturing Market,

By Source, 2023–2030 (Usd Million)

Table 317 Middle East: Biopharmaceutical Contract Manufacturing Market,

By Molecule Type, 2023–2030 (Usd Million)

Table 318 Middle East: Biopharmaceutical Contract Manufacturing Market,

By Therapeutic Area, 2023–2030 (Usd Million)

Table 319 Gcc Countries: Biopharmaceutical Contract Manufacturing Market,

By Service, 2023–2030 (Usd Million)

Table 320 Gcc Countries: Biopharmaceutical Contract Manufacturing Market,

By Type, 2023–2030 (Usd Million)

Table 321 Gcc Countries: Biopharmaceutical Contract Manufacturing Market,

By Scale Of Operation, 2023–2030 (Usd Million)

Table 322 Gcc Countries: Biopharmaceutical Contract Manufacturing Market,

By Source, 2023–2030 (Usd Million)

Table 323 Gcc Countries: Biopharmaceutical Contract Manufacturing Market,

By Molecule Type, 2023–2030 (Usd Million)

Table 324 Gcc Countries: Biopharmaceutical Contract Manufacturing Market,

By Therapeutic Area, 2023–2030 (Usd Million)

Table 325 Rest Of Middle East: Biopharmaceutical Contract Manufacturing Market, By Service, 2023–2030 (Usd Million)

Table 326 Rest Of Middle East: Biopharmaceutical Contract Manufacturing Market, By Type, 2023–2030 (Usd Million)

Table 327 Rest Of Middle East: Biopharmaceutical Contract Manufacturing Market, By Scale Of Operation, 2023–2030 (Usd Million)

Table 328 Rest Of Middle East: Biopharmaceutical Contract Manufacturing Market, By Source, 2023–2030 (Usd Million)

Table 329 Rest Of Middle East: Biopharmaceutical Contract Manufacturing Market, By Molecule Type, 2023–2030 (Usd Million)

Table 330 Rest Of Middle East: Biopharmaceutical Contract Manufacturing Market, By Therapeutic Area, 2023–2030 (Usd Million)

Table 331 Africa: Key Macroindicators

Table 332 Africa: Biopharmaceutical Contract Manufacturing Market, By Service, 2023–2030 (Usd Million)

Table 333 Africa: Biopharmaceutical Contract Manufacturing Market, By Type, 2023–2030 (Usd Million)

Table 334 Africa: Biopharmaceutical Contract Manufacturing Market, By Scale Of Operation, 2023–2030 (Usd Million)

Table 335 Africa: Biopharmaceutical Contract Manufacturing Market, By Source, 2023–2030 (Usd Million)

Table 336 Africa: Biopharmaceutical Contract Manufacturing Market,

By Molecule Type, 2023–2030 (Usd Million)

Table 337 Africa: Biopharmaceutical Contract Manufacturing Market,

By Therapeutic Area, 2023–2030 (Usd Million)

Table 338 Strategies Deployed By Key Players

Table 339 Biopharmaceutical Contract Manufacturing Market:

Degree Of Competition

Table 340 Biopharmaceutical Contract Manufacturing Market: Region Footprint

Table 341 Biopharmaceutical Contract Manufacturing Market:

Service Type Footprint

Table 342 Biopharmaceutical Contract Manufacturing Market:

Molecule Type Footprint

Table 343 Biopharmaceutical Contract Manufacturing Market:

Therapeutic Area Footprint

Table 344 Biopharmaceutical Contract Manufacturing Market:

Detailed List Of Key Smes/Startups

Table 345 Biopharmaceutical Contract Manufacturing Market: Competitive Benchmarking Of Key Emerging Players/Startups, 2024

Table 346 Biopharmaceutical Contract Manufacturing Market: Service Launches, January 2022–june 2025

Table 347 Biopharmaceutical Contract Manufacturing Market:

Deals, January 2022–june 2025

Table 348 Biopharmaceutical Contract Manufacturing Market:

Expansions, January 2022– June 2025

Table 349 Lonza: Company Overview

Table 350 Lonza: Services Offered

Table 351 Lonza: Deals, January 2022–june 2025

Table 352 Lonza: Expansions, January 2022–june 2025

Table 353 Wuxi Biologics: Company Overview

Table 354 Wuxi Biologics: Services Offered

Table 355 Wuxi Biologics: Deals, January 2022–june 2025

Table 356 Wuxi Biologics: Expansions, January 2022– June 2025

Table 357 Samsung Biologics: Company Overview

Table 358 Samsung Biologics: Services Offered

Table 359 Samsung Biologics: Service Launches, January 2022–june 2025

Table 360 Samsung Biologics: Deals, January 2022–june 2025

Table 361 Samsung Biologics: Expansions, January 2022–june 2025

Table 362 Thermo Fisher Scientific Inc.: Company Overview

Table 363 Thermo Fisher Scientific Inc.: Services Offered

Table 364 Thermo Fisher Scientific Inc.: Deals, January 2022–june 2025

Table 365 Abbvie Inc.: Company Overview

Table 366 Abbvie Inc.: Services Offered

Table 367 Catalent, Inc.: Company Overview

Table 368 Catalent, Inc.: Services Offered

Table 369 Catalent, Inc.: Deals, January 2022–june 2025

Table 370 Catalent, Inc.: Expansions, January 2022–june 2025

Table 371 Boehringer Ingelheim International Gmbh: Company Overview

Table 372 Boehringer Ingelheim International Gmbh: Services Offered

Table 373 Boehringer Ingelheim International Gmbh: Other Developments, January 2022–june 2025

Table 374 Fujifilm Holdings Corporation: Company Overview

Table 375 Fujifilm Holdings Corporation: Services Offered

Table 376 Fujifilm Holdings Corporation: Deals, January 2022–june 2025

Table 377 Fujifilm Holdings Corporation: Expansions, January 2022–june 2025

Table 378 Eurofins Scientific: Company Overview

Table 379 Eurofins Scientific: Services Offered

Table 380 Eurofins Scientific: Expansions, January 2022–june 2025

Table 381 Genscript Biotech Corporation: Company Overview

Table 382 Genscript Biotech Corporation: Services Offered

Table 383 Genscript Biotech Corporation: Service Launches,

January 2022–june 2025

Table 384 Genscript Biotech Corporation: Deals, January 2022–june 2025

Table 385 Genscript Biotech Corporation: Expansions, January 2022–june 2025

Table 386 Acg Inc.: Company Overview

Table 387 Agc Inc.: Services Offered

Table 388 Agc Inc: Deals, January 2022–june 2025

Table 389 Agc Inc.: Expansions, January 2022–june 2025

Table 390 Merck Kgaa: Company Overview

Table 391 Merck Kgaa: Services Offered

Table 392 Merck Kgaa: Deals, January 2022–june 2025

Table 393 Merck Kgaa: Expansions, January 2022–june 2025

Table 394 Jsr Corporation: Company Overview

Table 395 Jsr Corporation: Services Offered

Table 396 Jsr Corporation: Expansions, January 2022–june 2025

Table 397 Idt Biologika: Company Overview

Table 398 Idt Biologika: Services Offered

Table 399 Idt Biologika: Other Developments, January 2022–june 2025

Table 400 Ajinomoto Bio-pharma: Company Overview

Table 401 Ajinomoto Bio-pharma: Services Offered

Table 402 Ajinomoto Bio-pharma: Deals, January 2022–june 2025

Table 403 Agilent Technologies Inc.: Company Overview

Table 404 Agilent Technologies Inc.: Services Offered

Table 405 Agilent Technologies Inc.: Deals, January 2022–june 2025

Table 406 Asahi Kasei Corporation: Company Overview

Table 407 Asahi Kasei Corporation: Services Offered

Table 408 Asahi Kasei Corporation: Deals, January 2022–june 2025

Table 409 Onesource Pharma Solutions: Company Overview

Table 410 Recipharm Ab: Company Overview

Table 411 Emergent: Company Overview

Table 412 Shanghai Fosun Pharmaceutical Co., Ltd.: Company Overview

Table 413 Lotte Biologics: Company Overview

Table 414 Curia Global, Inc.: Company Overview

Table 415 Polyplus Transfection: Company Overview

Table 416 Aldevron Llc: Company Overview

Table 417 Minapharm Pharmaceuticals: Company Overview

Table 418 Rentschler Biopharma Se: Company Overview

Table 419 Porton Pharma Solutions: Company Overview

Table 420 Cellares, Inc.: Company Overview

Table 421 Mabplex International Co., Ltd.: Company Overview

Table 422 Asymchem Inc.: Company Overview

Figures List

Figure 1 Biopharmaceutical Contract Manufacturing Market

Segmentation & Regional Scope

Figure 2 Biopharmaceutical Contract Manufacturing Market: Years Considered

Figure 3 Biopharmaceutical Contract Manufacturing Market: Research Design

Figure 4 Biopharmaceutical Contract Manufacturing Market:

Key Data From Secondary Sources

Figure 5 Biopharmaceutical Contract Manufacturing Market:

Breakdown Of Primary Interviews

Figure 6 Biopharmaceutical Contract Manufacturing Market Size Estimation (Supply-side Analysis), 2024

Figure 7 Company Revenue Analysis-based Estimation:

Bottom-up Approach (2024)

Figure 8 Revenue Share Analysis Of Thermo Fisher Scientific Inc. (2024)

Figure 9 Biopharmaceutical Contract Manufacturing Market Size Validation From Primary Sources

Figure 10 Biopharmaceutical Contract Manufacturing Market:

Top-down Approach

Figure 11 Biopharmaceutical Contract Manufacturing Market: Cagr Projections

Figure 12 Biopharmaceutical Contract Manufacturing Market:

Data Triangulation

Figure 13 Biopharmaceutical Contract Manufacturing Market, By Service,

2025 Vs. 2030 (Usd Million)

Figure 14 Biopharmaceutical Contract Manufacturing Market, By Type,

2025 Vs. 2030 (Usd Million)

Figure 15 Biopharmaceutical Contract Manufacturing Market, By Source,

2025 Vs. 2030 (Usd Million)

Figure 16 Geographical Snapshot Of Biopharmaceutical Contract

Manufacturing Market

Figure 17 Increasing Approvals Of Biologics To Drive Market Growth During Forecast Period

Figure 18 Commercial Operations Segment To Account For

Largest Share Of North American Market In 2025

Figure 19 Oncology Segment To Continue To Dominate Market In 2030

Figure 20 Monoclonal Antibodies To Continue To Dominate Market In 2030

Figure 21 Asia Pacific To Be Fastest-growing Market In Biopharmaceutical Contract Manufacturing Market During Forecast Period

Figure 22 Biopharmaceutical Contract Manufacturing Market: Drivers, Restraints, Opportunities, And Challenges

Figure 23 Personalized Medicines (% Of All Fda-approved Drugs), 2015–2024

Figure 24 Trends/Disruptions Impacting Customers’ Businesses

Figure 25 Biopharmaceutical Contract Manufacturing Market:

Value Chain Analysis

Figure 26 Biopharmaceutical Contract Manufacturing Market: Ecosystem Map

Figure 27 Patent Analysis Of Biopharmaceutical Contract Manufacturing Market, January 2014–december 2024

Figure 28 Biopharmaceutical Contract Manufacturing Market:

Porter’s Five Forces Analysis

Figure 29 Influence Of Stakeholders On Buying Process Of

Biopharmaceutical Contract Manufacturing Services

Figure 30 Key Buying Criteria For Biopharmaceutical Contract Manufacturing Services, By End User

Figure 31 Biopharmaceutical Contract Manufacturing Market:

Investment & Funding Scenario

Figure 32 North America: Biopharmaceutical Contract

Manufacturing Market Snapshot

Figure 33 Asia Pacific: Biopharmaceutical Contract Manufacturing Market Snapshot

Figure 34 Revenue Analysis Of Key Players In Biopharmaceutical Contract Manufacturing Market, 2020–2024 (Usd Million)

Figure 35 Market Share Analysis Of Key Players In Biopharmaceutical Contract Manufacturing Market (2024)

Figure 36 Biopharmaceutical Contract Manufacturing Market:

Company Evaluation Matrix (Key Players), 2024

Figure 37 Biopharmaceutical Contract Manufacturing Market:

Company Footprint

Figure 38 Biopharmaceutical Contract Manufacturing Market:

Company Evaluation Matrix (Smes/Startups), 2024

Figure 39 Ev/Ebitda Of Key Vendors

Figure 40 Year-to-date (Ytd) Price Total Return And 5-year Stock

Beta Of Key Vendors

Figure 41 Biopharmaceutical Contract Manufacturing Market:

Brand/Product Comparative Analysis

Figure 42 Lonza: Company Snapshot (2024)

Figure 43 Wuxi Biologics: Company Snapshot (2024)

Figure 44 Samsung Biologics: Company Snapshot (2024)

Figure 45 Thermo Fisher Scientific Inc.: Company Snapshot (2024)

Figure 46 Abbvie Inc.: Company Snapshot (2024)

Figure 47 Catalent, Inc.: Company Snapshot (2024)

Figure 48 Boehringer Ingelheim International Gmbh: Company Snapshot (2024)

Figure 49 Fujifilm Holdings Corporation: Company Snapshot (2024)

Figure 50 Eurofins Scientific: Company Snapshot (2024)

Figure 51 Sgenscript Biotech Corporation: Company Snapshot (2024)

Figure 52 Agc Inc.: Company Snapshot (2024)

Figure 53 Merck Kgaa: Company Snapshot (2024)

Figure 54 Jsr Corporation: Company Snapshot (2024)

Figure 55 Ajinomoto Bio-pharma: Company Snapshot (2024)

Figure 56 Agilent Technologies Inc.: Company Snapshot (2024)

Figure 57 Asahi Kasei Corporation: Company Snapshot (2024)